Biogen Soars As FDA Boasts Alzheimer's Drug - BW Healthcare World

Biogen's shares rose 2 per cent on Monday as a unanimous backing of its Alzheimer's drug by the U.S. health regulator's advisers strengthened the case for a traditional approval with no major new safe...